English | Español
Patient Daily | Mar 22, 2026

Study links climate change to increased dengue outbreaks after extreme weather events
Patient Daily | Mar 22, 2026

Lab Thread offers free lab software platform to academic and non-profit researchers
Patient Daily | Mar 22, 2026

Sartorius launches Eveo Cell Therapy Platform to address manufacturing bottlenecks
Patient Daily | Mar 22, 2026

American Lung Association urges pneumococcal vaccination for adults at risk
Patient Daily | Mar 22, 2026

Excalipoint Therapeutics announces $68.7 million seed funding for cancer immunotherapy pipeline
Patient Daily | Mar 22, 2026

Pharma industry may see larger mergers as companies face patent cliffs and pricing shifts
Patient Daily | Mar 22, 2026

Kennedy’s vaccine agenda faces setback as obesity drug developments continue
Patient Daily | Mar 22, 2026

TerraPower announces $450 million radioisotope plant in Philadelphia

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Regulatory
Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'